Moreover, substance P increased the expression of neurokinin receptor 1 in metastatic BC cells (but not that of neurokinin receptor 2) and favored the secretion of a bradykinin precursor (high-molecular-weight kininogen compound) that mediated tumorigenic effects [178]. Here, TACR2 is linked to breast cancer.